Loading company
HeartSciences Inc.
HSCS · Nasdaq · ·
$4.12-6.0%Sep 29 close
- 1M
- +36.0%
- 6M
- +82.3%
- 1Y
- +18.4%
HSCS · Nasdaq · ·
$4.12-6.0%Sep 29 close
The quarter ending July 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toJul 31, 2026 | 3 months toJul 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $2.1K | $1.9K | +10.53% |
| Profit | -$3.2M | -$2.1M | -54.37% |
| Profit per share | -$0.85 | -$0.22 | -286.36% |
| Free Cash Flow | -$1.7M | -$1.6M | -3.14% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
HeartSciences Inc. has no earnings call transcript available.
“This has been a period of significant change for the Company. The proposed combination with Fortitude is expected to give our shareholders exposure to a business that is a meaningful participant in the Zcash ecosystem. In our view, it represents a significant opportunity for shareholders and the transaction continues to move toward closing,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
HeartSciences is a healthcare information technology company advancing the use of ECG/EKGs through the integration of artificial intelligence. HeartSciences’ MyoVista Insights™ Platform is a cloud-native, vendor- and device-agnostic ECG management system designed to modernize ECG workflows and improve clinical efficiency and decision-making. The platform’s AI-ECG marketplace is designed to deliver AI-ECG algorithms into clinical workflows across a health system’s existing ECG equipment.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from HeartSciences Inc.’s Item 2.02 8-K filed September 15, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.